谷歌浏览器插件
订阅小程序
在清言上使用

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Olanzapine Based Prophylactic Antiemetic Therapy for Delayed and Persistent Nausea and Vomiting in Patients with HER2-positive or HER2-low Breast Cancer Treated with Trastuzumab Deruxtecan: ERICA Study (WJOG14320B)

H. Sakai,J. Tsurutani, Y. Ozaki,H. Ishiguro, K. Nozawa,T. Yamanaka, K. Aogi,K. Matsumoto, T. Iwasa, M. Tokiwa,M. Tsuneizumi, Y. Miyoshi, C. Kitagawa, M. Yamamoto, Y. Takano,C. K. Imamura,Y. Chiba, D. Takiguchi, T. Ezumi, T. Takano

ANNALS OF ONCOLOGY(2025)

引用 0|浏览3
关键词
trastuzumab deruxtecan,nausea,olanzapine,vomiting,persistent phase
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要